Delivery Order SPE2DB22D1106-SPE2DB25FEQJ2

Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, with a ceiling value of $5,400.42 and a period of performance through May 22, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250MG 30S, a prescription medication, with a ceiling value of $1,672.50 and a period of performance through June 12, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, with a firm fixed price of $2,529.31 and a completion date of May 22, 2025. The contract is not set aside and was awarded under Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,039.60, is for the delivery of Armodafinil 250 mg tablets. It is a firm fixed-price, non-set-aside contract with a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,793.26 firm fixed-price contract is for the delivery of 4567733105 ARMODAFINIL 250 MG TABLET 30S and has an ultimate completion date of March 31, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,688.25, is for the delivery of ARMODAFINIL 250 MG TABLET 30S. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 9, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. This contract is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, a medication used to treat sleep disorders, with a ceiling value of $1,672.50. The contract is a firm fixed price, non-set-aside award with a period of performance through May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, a pharmaceutical product, with a firm fixed-price ceiling value of $1,114.90 and an ultimate completion date of May 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit company registered in...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,246.36, is for the supply of 4567750841 ARMODAFINIL 250 MG TABLET 30S to support federal healthcare programs. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,192,477 units of the prescription medication armodafinil 250 mg tablets. The contract has a firm fixed price of $1,672.35 and a completion date of May 9, 2025. This award is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEQJ2
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARMODAFINIL 250 MG TABLET 30S, a pharmaceutical product, with a firm fixed price of $2,787.50 and a performance period ending on May 29, 2025.

The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of the broader IDC, allowing the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/27/25, 9:46 AM